Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Blood management company Haemonetics has acquired Haemoscope Corporation's TEG Thrombelastograph Hemostasis Analyzer business for $44 million in cash.
Subscribe to our email newsletter
The transaction represents Haemonetics’s third blood management-related acquisition in 2007.
Chris Lindop, CFO of Haemonetics, said: “The TEG business acquisition is strategic and strengthens our vision of being a global leader in blood management for our customers. The business expands Haemonetics’s product portfolio by providing clinicians with a diagnostic tool to optimize blood management practice.”